Literature DB >> 14679323

Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.

Roy Dekel1, Stephanie D Martinez-Hawthorne, R Jose Guillen, Ronnie Fass.   

Abstract

BACKGROUND: Symptom index (SI), which represents the percentage of perceived gastroesophageal reflux-related symptoms that correlate with esophageal acid reflux events (pH <4), has been suggested as a measure to improve diagnosis of gastroesophageal reflux (GER)-related noncardiac chest pain (NCCP). Because no study has evaluated the value of the symptom index in NCCP patients, data to support this claim have yet to be elucidated. AIM: To evaluate the value of SI in identifying gastroesophageal reflux disease (GERD)-related NCCP patients.
METHODS: Patients enrolled in this study were referred by a cardiologist after a comprehensive work-up excluded a cardiac cause for their chest pain. All patients underwent upper endoscopy to determine esophageal inflammation and 24-hour esophageal pH monitoring to assess esophageal acid exposure. Patients were instructed to record all chest pain episodes during the pH test. Patients with a positive SI (> or =50%) underwent the proton pump inhibitors (PPI) test, which is a therapeutic trial using a short course of high dose PPI.
RESULTS: A total of 94 patients with NCCP were included in this study. Forty-seven (50%) had either a positive upper endoscopy or an abnormal pH test and were considered GERD-Positive. Forty-seven patients (50%) had both tests negative and were considered GERD-Negative. Total number of reflux episodes and percent total, supine and upright time pH less than 4, were significantly higher in the GERD-Positive group as compared with the GERD-Negative group (P < 0.0001, P < 0.0001, P = 0.0045, and P < 0.0001 respectively). Only 9 (19.1%) patients in the GERD-Positive group and 5 (10.6%) patients in the GERD-Negative group had a positive SI (p = ns). Eight (89%) out of the 9 patients who had a positive SI in the GERD-Positive group and 2 (40%) out of 5 patients in the GERD-Negative group responded to the PPI test.
CONCLUSION: Positive SI is relatively uncommon in NCCP patients, regardless if GERD is present or absent. Hence, symptom index provides very little improvement in diagnosing GERD-related NCCP.

Entities:  

Mesh:

Year:  2004        PMID: 14679323     DOI: 10.1097/00004836-200401000-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Identifying and managing functional cardiac symptoms.

Authors:  Jonathan Rogers; George Collins; Mujtaba Husain; Mary Docherty
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 2.  How to Diagnose and Treat Functional Chest Pain.

Authors:  Jose M Remes-Troche
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

3.  Noncardiac chest pain: current treatment.

Authors:  Ron Schey; Autumn Villarreal; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

4.  Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.

Authors:  Vladimir M Kushnir; Gregory S Sayuk; C Prakash Gyawali
Journal:  Am J Gastroenterol       Date:  2009-11-17       Impact factor: 10.864

5.  Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.

Authors:  A Patel; G S Sayuk; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2016-04-08       Impact factor: 3.598

6.  Determinants of the Association between Non-Cardiac Chest Pain and Reflux.

Authors:  Thomas V K Herregods; Albert J Bredenoord; Jacobus M Oors; Auke Bogte; André J P M Smout
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

7.  Bravo 48-hour Wireless pH Monitoring in Patients With Non-cardiac Chest Pain. Objective Gastroesophageal Reflux Disease Parameters Predict the Responses to Proton Pump Inhibitors.

Authors:  Georgios Karamanolis; Konstantinos Triantafyllou; Panagiota Psatha; Ioannis Vlachogiannakos; Asimina Gaglia; Dimitrios Polymeros; Smaragdi Fessatou; Maria Triantafyllou; Ioannis S Papanikolaou; Spiros D Ladas
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

8.  Recent advances in noncardiac chest pain in Korea.

Authors:  Jeong Hwan Kim; Poong-Lyul Rhee
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

Review 9.  Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis.

Authors:  Maria M Wertli; Katrin B Ruchti; Johann Steurer; Ulrike Held
Journal:  BMC Med       Date:  2013-11-08       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.